Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-20

Clinical Trial Update: GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update for GWMD1092 (GWP42003/GWP42004) in type 2 diabetes and dyslipidemia; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GWMD1092 (GWP42003)
  • GWP42004

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Dyslipidemias, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-01-20